nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—Entecavir—hepatitis B	0.272	0.547	CrCtD
Cladribine—Telbivudine—hepatitis B	0.225	0.453	CrCtD
Cladribine—DCK—Lamivudine—hepatitis B	0.087	0.571	CbGbCtD
Cladribine—Trifluridine—Telbivudine—hepatitis B	0.0504	0.181	CrCrCtD
Cladribine—Idoxuridine—Telbivudine—hepatitis B	0.0504	0.181	CrCrCtD
Cladribine—Floxuridine—Telbivudine—hepatitis B	0.0459	0.165	CrCrCtD
Cladribine—Pentostatin—Telbivudine—hepatitis B	0.0459	0.165	CrCrCtD
Cladribine—Decitabine—Entecavir—hepatitis B	0.0333	0.119	CrCrCtD
Cladribine—Decitabine—Telbivudine—hepatitis B	0.0276	0.099	CrCrCtD
Cladribine—Decitabine—Lamivudine—hepatitis B	0.0252	0.0905	CrCrCtD
Cladribine—SLC22A2—Lamivudine—hepatitis B	0.0251	0.165	CbGbCtD
Cladribine—SLC22A1—Lamivudine—hepatitis B	0.0218	0.143	CbGbCtD
Cladribine—ABCG2—Lamivudine—hepatitis B	0.0185	0.122	CbGbCtD
Cladribine—Viral skin infection—Lamivudine—hepatitis B	0.00762	0.177	CcSEcCtD
Cladribine—PNP—blood plasma—hepatitis B	0.0022	0.156	CbGeAlD
Cladribine—Breath sounds abnormal—Lamivudine—hepatitis B	0.00138	0.0319	CcSEcCtD
Cladribine—POLE2—blood—hepatitis B	0.00127	0.0903	CbGeAlD
Cladribine—POLE2—Global Genomic NER (GG-NER)—DDB1—hepatitis B	0.00119	0.0898	CbGpPWpGaD
Cladribine—POLE4—liver—hepatitis B	0.00114	0.0808	CbGeAlD
Cladribine—Localised oedema—Lamivudine—hepatitis B	0.00104	0.0242	CcSEcCtD
Cladribine—POLE2—Floxuridine—Telbivudine—hepatitis B	0.000998	1	CbGdCrCtD
Cladribine—POLE2—liver—hepatitis B	0.000995	0.0706	CbGeAlD
Cladribine—POLE2—Nucleotide Excision Repair—DDB1—hepatitis B	0.000876	0.066	CbGpPWpGaD
Cladribine—Skin infection—Lamivudine—hepatitis B	0.000873	0.0203	CcSEcCtD
Cladribine—PNP—blood—hepatitis B	0.000805	0.0571	CbGeAlD
Cladribine—POLE—Global Genomic NER (GG-NER)—DDB1—hepatitis B	0.000768	0.0579	CbGpPWpGaD
Cladribine—RRM2B—blood—hepatitis B	0.000747	0.053	CbGeAlD
Cladribine—POLE3—blood—hepatitis B	0.000706	0.0501	CbGeAlD
Cladribine—Opportunistic infection—Lamivudine—hepatitis B	0.000655	0.0152	CcSEcCtD
Cladribine—PNP—liver—hepatitis B	0.00063	0.0447	CbGeAlD
Cladribine—NR5A1—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.000586	0.0441	CbGpPWpGaD
Cladribine—RRM2B—liver—hepatitis B	0.000584	0.0415	CbGeAlD
Cladribine—Bone pain—Adefovir Dipivoxil—hepatitis B	0.00058	0.0135	CcSEcCtD
Cladribine—POLE—Nucleotide Excision Repair—DDB1—hepatitis B	0.000564	0.0425	CbGpPWpGaD
Cladribine—POLE3—liver—hepatitis B	0.000552	0.0392	CbGeAlD
Cladribine—POLE—blood—hepatitis B	0.000539	0.0382	CbGeAlD
Cladribine—NR5A1—Nuclear Receptors—HNF4A—hepatitis B	0.000514	0.0387	CbGpPWpGaD
Cladribine—Musculoskeletal pain—Telbivudine—hepatitis B	0.000474	0.011	CcSEcCtD
Cladribine—POLA1—blood—hepatitis B	0.000465	0.033	CbGeAlD
Cladribine—Hepatic failure—Entecavir—hepatitis B	0.00046	0.0107	CcSEcCtD
Cladribine—POLE2—DNA Repair—DDB1—hepatitis B	0.000456	0.0344	CbGpPWpGaD
Cladribine—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.000449	0.0104	CcSEcCtD
Cladribine—RRM2—blood—hepatitis B	0.000444	0.0315	CbGeAlD
Cladribine—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.000424	0.00984	CcSEcCtD
Cladribine—POLE—liver—hepatitis B	0.000421	0.0299	CbGeAlD
Cladribine—Respiratory tract infection—Lamivudine—hepatitis B	0.00042	0.00974	CcSEcCtD
Cladribine—RRM1—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.000418	0.0315	CbGpPWpGaD
Cladribine—Sepsis—Telbivudine—hepatitis B	0.000406	0.00943	CcSEcCtD
Cladribine—NR5A1—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.000406	0.0306	CbGpPWpGaD
Cladribine—RRM1—blood—hepatitis B	0.000369	0.0262	CbGeAlD
Cladribine—POLA1—liver—hepatitis B	0.000363	0.0258	CbGeAlD
Cladribine—Renal impairment—Telbivudine—hepatitis B	0.000357	0.00829	CcSEcCtD
Cladribine—RRM2—liver—hepatitis B	0.000347	0.0246	CbGeAlD
Cladribine—RRM2—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.000344	0.0259	CbGpPWpGaD
Cladribine—Pain in extremity—Telbivudine—hepatitis B	0.00034	0.00789	CcSEcCtD
Cladribine—Neutropenia—Entecavir—hepatitis B	0.000334	0.00776	CcSEcCtD
Cladribine—Upper respiratory tract infection—Entecavir—hepatitis B	0.000332	0.00771	CcSEcCtD
Cladribine—Blood disorder—Lamivudine—hepatitis B	0.000316	0.00733	CcSEcCtD
Cladribine—Renal failure—Entecavir—hepatitis B	0.000313	0.00727	CcSEcCtD
Cladribine—Renal failure—Adefovir Dipivoxil—hepatitis B	0.000306	0.00709	CcSEcCtD
Cladribine—Hepatobiliary disease—Entecavir—hepatitis B	0.000301	0.007	CcSEcCtD
Cladribine—Muscular weakness—Telbivudine—hepatitis B	0.0003	0.00696	CcSEcCtD
Cladribine—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.000294	0.00683	CcSEcCtD
Cladribine—POLE—DNA Repair—DDB1—hepatitis B	0.000294	0.0221	CbGpPWpGaD
Cladribine—Bone disorder—Lamivudine—hepatitis B	0.000292	0.00678	CcSEcCtD
Cladribine—RRM1—liver—hepatitis B	0.000288	0.0205	CbGeAlD
Cladribine—DCK—blood—hepatitis B	0.000286	0.0203	CbGeAlD
Cladribine—Oedema peripheral—Entecavir—hepatitis B	0.000282	0.00654	CcSEcCtD
Cladribine—Abdominal discomfort—Telbivudine—hepatitis B	0.000281	0.00653	CcSEcCtD
Cladribine—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.000277	0.00643	CcSEcCtD
Cladribine—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.000276	0.0064	CcSEcCtD
Cladribine—Neutropenia—Telbivudine—hepatitis B	0.000275	0.00637	CcSEcCtD
Cladribine—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.000274	0.00637	CcSEcCtD
Cladribine—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.000274	0.00635	CcSEcCtD
Cladribine—Upper respiratory tract infection—Telbivudine—hepatitis B	0.000273	0.00633	CcSEcCtD
Cladribine—RRM2B—DNA Damage Response—FAS—hepatitis B	0.000272	0.0205	CbGpPWpGaD
Cladribine—Inflammation—Lamivudine—hepatitis B	0.000272	0.00631	CcSEcCtD
Cladribine—Musculoskeletal pain—Lamivudine—hepatitis B	0.000267	0.0062	CcSEcCtD
Cladribine—RRM2B—miRNA Regulation of DNA Damage Response—FAS—hepatitis B	0.000263	0.0198	CbGpPWpGaD
Cladribine—Immune system disorder—Entecavir—hepatitis B	0.000258	0.006	CcSEcCtD
Cladribine—Renal failure—Telbivudine—hepatitis B	0.000257	0.00597	CcSEcCtD
Cladribine—Wheezing—Lamivudine—hepatitis B	0.000256	0.00595	CcSEcCtD
Cladribine—Alopecia—Entecavir—hepatitis B	0.000253	0.00587	CcSEcCtD
Cladribine—Mental disorder—Entecavir—hepatitis B	0.000251	0.00582	CcSEcCtD
Cladribine—Malnutrition—Entecavir—hepatitis B	0.000249	0.00578	CcSEcCtD
Cladribine—Aplastic anaemia—Lamivudine—hepatitis B	0.000248	0.00575	CcSEcCtD
Cladribine—Hepatobiliary disease—Telbivudine—hepatitis B	0.000248	0.00575	CcSEcCtD
Cladribine—SLC22A1—blood—hepatitis B	0.000244	0.0173	CbGeAlD
Cladribine—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.000243	0.00564	CcSEcCtD
Cladribine—Flatulence—Adefovir Dipivoxil—hepatitis B	0.000239	0.00556	CcSEcCtD
Cladribine—Back pain—Adefovir Dipivoxil—hepatitis B	0.000235	0.00546	CcSEcCtD
Cladribine—Pharyngitis—Telbivudine—hepatitis B	0.000233	0.00541	CcSEcCtD
Cladribine—Connective tissue disorder—Telbivudine—hepatitis B	0.000231	0.00536	CcSEcCtD
Cladribine—Sepsis—Lamivudine—hepatitis B	0.000229	0.00531	CcSEcCtD
Cladribine—Anaemia—Adefovir Dipivoxil—hepatitis B	0.000225	0.00521	CcSEcCtD
Cladribine—DCK—liver—hepatitis B	0.000224	0.0159	CbGeAlD
Cladribine—Phlebitis—Lamivudine—hepatitis B	0.000222	0.00516	CcSEcCtD
Cladribine—Cough—Adefovir Dipivoxil—hepatitis B	0.000212	0.00492	CcSEcCtD
Cladribine—Mediastinal disorder—Telbivudine—hepatitis B	0.000212	0.00492	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.000211	0.00489	CcSEcCtD
Cladribine—Chest pain—Adefovir Dipivoxil—hepatitis B	0.000207	0.0048	CcSEcCtD
Cladribine—Myalgia—Adefovir Dipivoxil—hepatitis B	0.000207	0.0048	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.000205	0.00477	CcSEcCtD
Cladribine—Malnutrition—Telbivudine—hepatitis B	0.000205	0.00475	CcSEcCtD
Cladribine—Infection—Entecavir—hepatitis B	0.000202	0.00469	CcSEcCtD
Cladribine—Renal impairment—Lamivudine—hepatitis B	0.000201	0.00467	CcSEcCtD
Cladribine—Nervous system disorder—Entecavir—hepatitis B	0.000199	0.00463	CcSEcCtD
Cladribine—Back pain—Telbivudine—hepatitis B	0.000198	0.00459	CcSEcCtD
Cladribine—Skin disorder—Entecavir—hepatitis B	0.000197	0.00458	CcSEcCtD
Cladribine—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.000194	0.00451	CcSEcCtD
Cladribine—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.000194	0.00451	CcSEcCtD
Cladribine—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.000193	0.00447	CcSEcCtD
Cladribine—SLC22A1—liver—hepatitis B	0.000191	0.0135	CbGeAlD
Cladribine—SLC28A3—Transport of vitamins, nucleosides, and related molecules—ALB—hepatitis B	0.00019	0.0143	CbGpPWpGaD
Cladribine—Ill-defined disorder—Telbivudine—hepatitis B	0.00019	0.00441	CcSEcCtD
Cladribine—Anorexia—Adefovir Dipivoxil—hepatitis B	0.000189	0.00439	CcSEcCtD
Cladribine—Malaise—Telbivudine—hepatitis B	0.000184	0.00428	CcSEcCtD
Cladribine—Insomnia—Entecavir—hepatitis B	0.000184	0.00427	CcSEcCtD
Cladribine—Somnolence—Entecavir—hepatitis B	0.000181	0.00419	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.000181	0.00419	CcSEcCtD
Cladribine—Cough—Telbivudine—hepatitis B	0.000179	0.00414	CcSEcCtD
Cladribine—Gastrointestinal disorder—Entecavir—hepatitis B	0.000175	0.00407	CcSEcCtD
Cladribine—Fatigue—Entecavir—hepatitis B	0.000175	0.00407	CcSEcCtD
Cladribine—Chest pain—Telbivudine—hepatitis B	0.000174	0.00404	CcSEcCtD
Cladribine—Myalgia—Telbivudine—hepatitis B	0.000174	0.00404	CcSEcCtD
Cladribine—Arthralgia—Telbivudine—hepatitis B	0.000174	0.00404	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.000173	0.00402	CcSEcCtD
Cladribine—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.000172	0.004	CcSEcCtD
Cladribine—Discomfort—Telbivudine—hepatitis B	0.000172	0.00399	CcSEcCtD
Cladribine—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.000171	0.00397	CcSEcCtD
Cladribine—Muscular weakness—Lamivudine—hepatitis B	0.000169	0.00392	CcSEcCtD
Cladribine—Gastrointestinal pain—Entecavir—hepatitis B	0.000166	0.00386	CcSEcCtD
Cladribine—Nervous system disorder—Telbivudine—hepatitis B	0.000164	0.0038	CcSEcCtD
Cladribine—Thrombocytopenia—Telbivudine—hepatitis B	0.000163	0.00379	CcSEcCtD
Cladribine—Skin disorder—Telbivudine—hepatitis B	0.000162	0.00376	CcSEcCtD
Cladribine—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.000162	0.00376	CcSEcCtD
Cladribine—Sweating increased—Lamivudine—hepatitis B	0.000161	0.00374	CcSEcCtD
Cladribine—Abdominal pain—Entecavir—hepatitis B	0.000161	0.00373	CcSEcCtD
Cladribine—Body temperature increased—Entecavir—hepatitis B	0.000161	0.00373	CcSEcCtD
Cladribine—ABCG2—blood—hepatitis B	0.00016	0.0113	CbGeAlD
Cladribine—Abdominal discomfort—Lamivudine—hepatitis B	0.000159	0.00368	CcSEcCtD
Cladribine—Pancytopenia—Lamivudine—hepatitis B	0.000157	0.00365	CcSEcCtD
Cladribine—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.000157	0.00364	CcSEcCtD
Cladribine—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.000157	0.00364	CcSEcCtD
Cladribine—Neutropenia—Lamivudine—hepatitis B	0.000155	0.00359	CcSEcCtD
Cladribine—RRM2B—Direct p53 effectors—FAS—hepatitis B	0.000153	0.0115	CbGpPWpGaD
Cladribine—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.000152	0.00353	CcSEcCtD
Cladribine—Insomnia—Telbivudine—hepatitis B	0.000151	0.00351	CcSEcCtD
Cladribine—Paraesthesia—Telbivudine—hepatitis B	0.00015	0.00348	CcSEcCtD
Cladribine—RRM2B—DNA Damage Response—CDKN1A—hepatitis B	0.000149	0.0113	CbGpPWpGaD
Cladribine—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.000146	0.0034	CcSEcCtD
Cladribine—Asthenia—Entecavir—hepatitis B	0.000146	0.00339	CcSEcCtD
Cladribine—Renal failure—Lamivudine—hepatitis B	0.000145	0.00337	CcSEcCtD
Cladribine—RRM2B—miRNA Regulation of DNA Damage Response—CDKN1A—hepatitis B	0.000144	0.0109	CbGpPWpGaD
Cladribine—Gastrointestinal disorder—Telbivudine—hepatitis B	0.000144	0.00335	CcSEcCtD
Cladribine—Fatigue—Telbivudine—hepatitis B	0.000144	0.00334	CcSEcCtD
Cladribine—Pain—Telbivudine—hepatitis B	0.000143	0.00331	CcSEcCtD
Cladribine—Asthenia—Adefovir Dipivoxil—hepatitis B	0.000142	0.0033	CcSEcCtD
Cladribine—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00014	0.00326	CcSEcCtD
Cladribine—Hepatobiliary disease—Lamivudine—hepatitis B	0.00014	0.00324	CcSEcCtD
Cladribine—Epistaxis—Lamivudine—hepatitis B	0.000139	0.00323	CcSEcCtD
Cladribine—Diarrhoea—Entecavir—hepatitis B	0.000139	0.00323	CcSEcCtD
Cladribine—Feeling abnormal—Telbivudine—hepatitis B	0.000138	0.00319	CcSEcCtD
Cladribine—Gastrointestinal pain—Telbivudine—hepatitis B	0.000137	0.00317	CcSEcCtD
Cladribine—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000136	0.00315	CcSEcCtD
Cladribine—Dizziness—Entecavir—hepatitis B	0.000134	0.00312	CcSEcCtD
Cladribine—Abdominal pain—Telbivudine—hepatitis B	0.000132	0.00306	CcSEcCtD
Cladribine—Body temperature increased—Telbivudine—hepatitis B	0.000132	0.00306	CcSEcCtD
Cladribine—Pharyngitis—Lamivudine—hepatitis B	0.000131	0.00305	CcSEcCtD
Cladribine—Connective tissue disorder—Lamivudine—hepatitis B	0.00013	0.00302	CcSEcCtD
Cladribine—Vomiting—Entecavir—hepatitis B	0.000129	0.003	CcSEcCtD
Cladribine—ABCG2—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.000129	0.00969	CbGpPWpGaD
Cladribine—Rash—Entecavir—hepatitis B	0.000128	0.00297	CcSEcCtD
Cladribine—Dermatitis—Entecavir—hepatitis B	0.000128	0.00297	CcSEcCtD
Cladribine—Headache—Entecavir—hepatitis B	0.000127	0.00296	CcSEcCtD
Cladribine—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000126	0.00293	CcSEcCtD
Cladribine—Erythema multiforme—Lamivudine—hepatitis B	0.000125	0.00291	CcSEcCtD
Cladribine—Rash—Adefovir Dipivoxil—hepatitis B	0.000125	0.0029	CcSEcCtD
Cladribine—ABCG2—liver—hepatitis B	0.000125	0.00886	CbGeAlD
Cladribine—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000125	0.0029	CcSEcCtD
Cladribine—Headache—Adefovir Dipivoxil—hepatitis B	0.000124	0.00288	CcSEcCtD
Cladribine—Nausea—Entecavir—hepatitis B	0.000121	0.0028	CcSEcCtD
Cladribine—Asthenia—Telbivudine—hepatitis B	0.00012	0.00278	CcSEcCtD
Cladribine—Immune system disorder—Lamivudine—hepatitis B	0.00012	0.00278	CcSEcCtD
Cladribine—Mediastinal disorder—Lamivudine—hepatitis B	0.000119	0.00277	CcSEcCtD
Cladribine—Chills—Lamivudine—hepatitis B	0.000119	0.00276	CcSEcCtD
Cladribine—Pruritus—Telbivudine—hepatitis B	0.000118	0.00274	CcSEcCtD
Cladribine—Nausea—Adefovir Dipivoxil—hepatitis B	0.000118	0.00273	CcSEcCtD
Cladribine—Alopecia—Lamivudine—hepatitis B	0.000117	0.00272	CcSEcCtD
Cladribine—Malnutrition—Lamivudine—hepatitis B	0.000115	0.00268	CcSEcCtD
Cladribine—Erythema—Lamivudine—hepatitis B	0.000115	0.00268	CcSEcCtD
Cladribine—Diarrhoea—Telbivudine—hepatitis B	0.000114	0.00265	CcSEcCtD
Cladribine—Flatulence—Lamivudine—hepatitis B	0.000114	0.00264	CcSEcCtD
Cladribine—POLE2—G1 to S cell cycle control—CDKN2A—hepatitis B	0.000112	0.00841	CbGpPWpGaD
Cladribine—Back pain—Lamivudine—hepatitis B	0.000112	0.00259	CcSEcCtD
Cladribine—Dizziness—Telbivudine—hepatitis B	0.00011	0.00256	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000109	0.00822	CbGpPWpGaD
Cladribine—Ill-defined disorder—Lamivudine—hepatitis B	0.000107	0.00248	CcSEcCtD
Cladribine—Anaemia—Lamivudine—hepatitis B	0.000107	0.00247	CcSEcCtD
Cladribine—Vomiting—Telbivudine—hepatitis B	0.000106	0.00246	CcSEcCtD
Cladribine—Rash—Telbivudine—hepatitis B	0.000105	0.00244	CcSEcCtD
Cladribine—Dermatitis—Telbivudine—hepatitis B	0.000105	0.00244	CcSEcCtD
Cladribine—Headache—Telbivudine—hepatitis B	0.000105	0.00243	CcSEcCtD
Cladribine—Malaise—Lamivudine—hepatitis B	0.000104	0.00241	CcSEcCtD
Cladribine—RRM2B—DNA Damage Response—TP53—hepatitis B	0.000102	0.00767	CbGpPWpGaD
Cladribine—NR5A1—Generic Transcription Pathway—NR0B2—hepatitis B	0.000101	0.00762	CbGpPWpGaD
Cladribine—Cough—Lamivudine—hepatitis B	0.000101	0.00234	CcSEcCtD
Cladribine—Nausea—Telbivudine—hepatitis B	9.92e-05	0.0023	CcSEcCtD
Cladribine—RRM2B—miRNA Regulation of DNA Damage Response—TP53—hepatitis B	9.83e-05	0.00741	CbGpPWpGaD
Cladribine—Arthralgia—Lamivudine—hepatitis B	9.82e-05	0.00228	CcSEcCtD
Cladribine—Myalgia—Lamivudine—hepatitis B	9.82e-05	0.00228	CcSEcCtD
Cladribine—Chest pain—Lamivudine—hepatitis B	9.82e-05	0.00228	CcSEcCtD
Cladribine—Anxiety—Lamivudine—hepatitis B	9.78e-05	0.00227	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	9.75e-05	0.00226	CcSEcCtD
Cladribine—Discomfort—Lamivudine—hepatitis B	9.7e-05	0.00225	CcSEcCtD
Cladribine—Confusional state—Lamivudine—hepatitis B	9.49e-05	0.0022	CcSEcCtD
Cladribine—Oedema—Lamivudine—hepatitis B	9.41e-05	0.00218	CcSEcCtD
Cladribine—Infection—Lamivudine—hepatitis B	9.35e-05	0.00217	CcSEcCtD
Cladribine—Nervous system disorder—Lamivudine—hepatitis B	9.23e-05	0.00214	CcSEcCtD
Cladribine—Thrombocytopenia—Lamivudine—hepatitis B	9.21e-05	0.00214	CcSEcCtD
Cladribine—Skin disorder—Lamivudine—hepatitis B	9.14e-05	0.00212	CcSEcCtD
Cladribine—POLE2—G1 to S cell cycle control—CDKN1A—hepatitis B	9.13e-05	0.00688	CbGpPWpGaD
Cladribine—Hyperhidrosis—Lamivudine—hepatitis B	9.1e-05	0.00211	CcSEcCtD
Cladribine—RRM1—Fluoropyrimidine Activity—TP53—hepatitis B	9.04e-05	0.00681	CbGpPWpGaD
Cladribine—Anorexia—Lamivudine—hepatitis B	8.97e-05	0.00208	CcSEcCtD
Cladribine—Hypotension—Lamivudine—hepatitis B	8.79e-05	0.00204	CcSEcCtD
Cladribine—RRM1—E2F transcription factor network—CDKN2A—hepatitis B	8.6e-05	0.00648	CbGpPWpGaD
Cladribine—Musculoskeletal discomfort—Lamivudine—hepatitis B	8.57e-05	0.00199	CcSEcCtD
Cladribine—Insomnia—Lamivudine—hepatitis B	8.51e-05	0.00198	CcSEcCtD
Cladribine—Paraesthesia—Lamivudine—hepatitis B	8.45e-05	0.00196	CcSEcCtD
Cladribine—Dyspnoea—Lamivudine—hepatitis B	8.39e-05	0.00195	CcSEcCtD
Cladribine—RRM2B—Direct p53 effectors—CDKN1A—hepatitis B	8.39e-05	0.00632	CbGpPWpGaD
Cladribine—RRM2B—Direct p53 effectors—PTEN—hepatitis B	8.37e-05	0.0063	CbGpPWpGaD
Cladribine—Somnolence—Lamivudine—hepatitis B	8.37e-05	0.00194	CcSEcCtD
Cladribine—Decreased appetite—Lamivudine—hepatitis B	8.18e-05	0.0019	CcSEcCtD
Cladribine—Gastrointestinal disorder—Lamivudine—hepatitis B	8.12e-05	0.00189	CcSEcCtD
Cladribine—Fatigue—Lamivudine—hepatitis B	8.11e-05	0.00188	CcSEcCtD
Cladribine—Constipation—Lamivudine—hepatitis B	8.05e-05	0.00187	CcSEcCtD
Cladribine—Pain—Lamivudine—hepatitis B	8.05e-05	0.00187	CcSEcCtD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	7.86e-05	0.00592	CbGpPWpGaD
Cladribine—Feeling abnormal—Lamivudine—hepatitis B	7.75e-05	0.0018	CcSEcCtD
Cladribine—Gastrointestinal pain—Lamivudine—hepatitis B	7.69e-05	0.00179	CcSEcCtD
Cladribine—POLE2—Retinoblastoma (RB) in Cancer—CDKN1A—hepatitis B	7.5e-05	0.00565	CbGpPWpGaD
Cladribine—Urticaria—Lamivudine—hepatitis B	7.48e-05	0.00174	CcSEcCtD
Cladribine—RRM2—Fluoropyrimidine Activity—TP53—hepatitis B	7.44e-05	0.00561	CbGpPWpGaD
Cladribine—Abdominal pain—Lamivudine—hepatitis B	7.44e-05	0.00173	CcSEcCtD
Cladribine—Body temperature increased—Lamivudine—hepatitis B	7.44e-05	0.00173	CcSEcCtD
Cladribine—POLE—G1 to S cell cycle control—CDKN2A—hepatitis B	7.2e-05	0.00542	CbGpPWpGaD
Cladribine—RRM2—E2F transcription factor network—CDKN2A—hepatitis B	7.09e-05	0.00534	CbGpPWpGaD
Cladribine—RRM1—E2F transcription factor network—CDKN1A—hepatitis B	7.03e-05	0.0053	CbGpPWpGaD
Cladribine—NR5A1—Generic Transcription Pathway—HNF4A—hepatitis B	7.01e-05	0.00528	CbGpPWpGaD
Cladribine—Hypersensitivity—Lamivudine—hepatitis B	6.93e-05	0.00161	CcSEcCtD
Cladribine—POLE2—Synthesis of DNA—CDKN1A—hepatitis B	6.93e-05	0.00522	CbGpPWpGaD
Cladribine—Asthenia—Lamivudine—hepatitis B	6.75e-05	0.00157	CcSEcCtD
Cladribine—Pruritus—Lamivudine—hepatitis B	6.66e-05	0.00155	CcSEcCtD
Cladribine—NR5A1—Developmental Biology—HNF4A—hepatitis B	6.6e-05	0.00497	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—AKR1B1—hepatitis B	6.6e-05	0.00497	CbGpPWpGaD
Cladribine—POLE2—DNA Replication—CDKN1A—hepatitis B	6.5e-05	0.0049	CbGpPWpGaD
Cladribine—POLE2—Mitotic G1-G1/S phases—CDKN2A—hepatitis B	6.45e-05	0.00486	CbGpPWpGaD
Cladribine—Diarrhoea—Lamivudine—hepatitis B	6.44e-05	0.00149	CcSEcCtD
Cladribine—RRM2B—Metabolism—GGT2—hepatitis B	6.32e-05	0.00476	CbGpPWpGaD
Cladribine—POLE2—G1/S Transition—CDKN1A—hepatitis B	6.26e-05	0.00471	CbGpPWpGaD
Cladribine—Dizziness—Lamivudine—hepatitis B	6.22e-05	0.00144	CcSEcCtD
Cladribine—POLE2—G1 to S cell cycle control—TP53—hepatitis B	6.22e-05	0.00468	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	6.15e-05	0.00463	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	6.15e-05	0.00463	CbGpPWpGaD
Cladribine—RRM1—Retinoblastoma (RB) in Cancer—CDKN1A—hepatitis B	6.11e-05	0.0046	CbGpPWpGaD
Cladribine—Vomiting—Lamivudine—hepatitis B	5.98e-05	0.00139	CcSEcCtD
Cladribine—Rash—Lamivudine—hepatitis B	5.93e-05	0.00138	CcSEcCtD
Cladribine—Dermatitis—Lamivudine—hepatitis B	5.93e-05	0.00138	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	5.93e-05	0.00446	CbGpPWpGaD
Cladribine—Headache—Lamivudine—hepatitis B	5.9e-05	0.00137	CcSEcCtD
Cladribine—POLE—G1 to S cell cycle control—CDKN1A—hepatitis B	5.88e-05	0.00443	CbGpPWpGaD
Cladribine—RRM2—E2F transcription factor network—CDKN1A—hepatitis B	5.79e-05	0.00436	CbGpPWpGaD
Cladribine—PNP—Metabolism—AKR1B1—hepatitis B	5.72e-05	0.00431	CbGpPWpGaD
Cladribine—RRM2B—Direct p53 effectors—TP53—hepatitis B	5.71e-05	0.0043	CbGpPWpGaD
Cladribine—POLE2—S Phase—CDKN1A—hepatitis B	5.68e-05	0.00428	CbGpPWpGaD
Cladribine—Nausea—Lamivudine—hepatitis B	5.59e-05	0.0013	CcSEcCtD
Cladribine—PNP—Metabolism—GGT2—hepatitis B	5.48e-05	0.00413	CbGpPWpGaD
Cladribine—POLE2—Mitotic G1-G1/S phases—CDKN1A—hepatitis B	5.28e-05	0.00397	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—KCNH1—hepatitis B	5.25e-05	0.00395	CbGpPWpGaD
Cladribine—POLE2—Retinoblastoma (RB) in Cancer—TP53—hepatitis B	5.11e-05	0.00384	CbGpPWpGaD
Cladribine—RRM2—Retinoblastoma (RB) in Cancer—CDKN1A—hepatitis B	5.03e-05	0.00379	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—KCNH1—hepatitis B	4.89e-05	0.00368	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—NR0B2—hepatitis B	4.87e-05	0.00367	CbGpPWpGaD
Cladribine—POLA1—E2F transcription factor network—CDKN2A—hepatitis B	4.85e-05	0.00365	CbGpPWpGaD
Cladribine—POLE—Retinoblastoma (RB) in Cancer—CDKN1A—hepatitis B	4.83e-05	0.00364	CbGpPWpGaD
Cladribine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—hepatitis B	4.7e-05	0.00354	CbGpPWpGaD
Cladribine—POLE—Synthesis of DNA—CDKN1A—hepatitis B	4.47e-05	0.00336	CbGpPWpGaD
Cladribine—RRM2—Mitotic G1-G1/S phases—CDKN2A—hepatitis B	4.33e-05	0.00326	CbGpPWpGaD
Cladribine—RRM2—G1/S Transition—CDKN1A—hepatitis B	4.2e-05	0.00316	CbGpPWpGaD
Cladribine—POLE—DNA Replication—CDKN1A—hepatitis B	4.19e-05	0.00315	CbGpPWpGaD
Cladribine—RRM1—Retinoblastoma (RB) in Cancer—TP53—hepatitis B	4.16e-05	0.00313	CbGpPWpGaD
Cladribine—POLE—Mitotic G1-G1/S phases—CDKN2A—hepatitis B	4.16e-05	0.00313	CbGpPWpGaD
Cladribine—SLC28A3—SLC-mediated transmembrane transport—ALB—hepatitis B	4.08e-05	0.00308	CbGpPWpGaD
Cladribine—POLE—G1/S Transition—CDKN1A—hepatitis B	4.03e-05	0.00304	CbGpPWpGaD
Cladribine—POLE—G1 to S cell cycle control—TP53—hepatitis B	4.01e-05	0.00302	CbGpPWpGaD
Cladribine—POLA1—E2F transcription factor network—CDKN1A—hepatitis B	3.96e-05	0.00298	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—CYP2A6—hepatitis B	3.83e-05	0.00289	CbGpPWpGaD
Cladribine—POLE—S Phase—CDKN1A—hepatitis B	3.66e-05	0.00276	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—NOS2—hepatitis B	3.65e-05	0.00275	CbGpPWpGaD
Cladribine—RRM2—Mitotic G1-G1/S phases—CDKN1A—hepatitis B	3.54e-05	0.00267	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—GOT2—hepatitis B	3.47e-05	0.00261	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	3.46e-05	0.00261	CbGpPWpGaD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—hepatitis B	3.44e-05	0.00259	CbGpPWpGaD
Cladribine—RRM2—Retinoblastoma (RB) in Cancer—TP53—hepatitis B	3.43e-05	0.00258	CbGpPWpGaD
Cladribine—POLE—Mitotic G1-G1/S phases—CDKN1A—hepatitis B	3.4e-05	0.00256	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—HNF4A—hepatitis B	3.38e-05	0.00254	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	3.34e-05	0.00251	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	3.34e-05	0.00251	CbGpPWpGaD
Cladribine—PNP—Metabolism—CYP2A6—hepatitis B	3.32e-05	0.0025	CbGpPWpGaD
Cladribine—POLE—Retinoblastoma (RB) in Cancer—TP53—hepatitis B	3.29e-05	0.00248	CbGpPWpGaD
Cladribine—RRM1—Metabolism—AKR1B1—hepatitis B	3.28e-05	0.00247	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	3.26e-05	0.00245	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	3.25e-05	0.00245	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	3.24e-05	0.00244	CbGpPWpGaD
Cladribine—DCK—Retinoblastoma (RB) in Cancer—TP53—hepatitis B	3.2e-05	0.00241	CbGpPWpGaD
Cladribine—POLA1—Synthesis of DNA—CDKN1A—hepatitis B	3.18e-05	0.0024	CbGpPWpGaD
Cladribine—RRM1—Metabolism—GGT2—hepatitis B	3.15e-05	0.00237	CbGpPWpGaD
Cladribine—PNP—Metabolism—GOT2—hepatitis B	3e-05	0.00226	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—GOT1—hepatitis B	2.99e-05	0.00225	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—GGT1—hepatitis B	2.99e-05	0.00225	CbGpPWpGaD
Cladribine—POLA1—DNA Replication—CDKN1A—hepatitis B	2.98e-05	0.00225	CbGpPWpGaD
Cladribine—POLA1—Mitotic G1-G1/S phases—CDKN2A—hepatitis B	2.96e-05	0.00223	CbGpPWpGaD
Cladribine—POLA1—G1/S Transition—CDKN1A—hepatitis B	2.87e-05	0.00216	CbGpPWpGaD
Cladribine—ABCG2—Fluoropyrimidine Activity—TP53—hepatitis B	2.78e-05	0.0021	CbGpPWpGaD
Cladribine—RRM2—Metabolism—AKR1B1—hepatitis B	2.71e-05	0.00204	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	2.69e-05	0.00203	CbGpPWpGaD
Cladribine—POLA1—S Phase—CDKN1A—hepatitis B	2.61e-05	0.00197	CbGpPWpGaD
Cladribine—PNP—Metabolism—GOT1—hepatitis B	2.59e-05	0.00195	CbGpPWpGaD
Cladribine—PNP—Metabolism—GGT1—hepatitis B	2.59e-05	0.00195	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GGT2—hepatitis B	2.59e-05	0.00195	CbGpPWpGaD
Cladribine—DCK—Metabolism—AKR1B1—hepatitis B	2.53e-05	0.0019	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	2.52e-05	0.0019	CbGpPWpGaD
Cladribine—DCK—Metabolism—GGT2—hepatitis B	2.42e-05	0.00183	CbGpPWpGaD
Cladribine—POLA1—Mitotic G1-G1/S phases—CDKN1A—hepatitis B	2.42e-05	0.00182	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—CDKN2A—hepatitis B	2.37e-05	0.00178	CbGpPWpGaD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—TP53—hepatitis B	2.34e-05	0.00177	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	2.22e-05	0.00167	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—CDKN2A—hepatitis B	2.12e-05	0.00159	CbGpPWpGaD
Cladribine—SLC28A3—Transmembrane transport of small molecules—ALB—hepatitis B	2.08e-05	0.00156	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—CTNNB1—hepatitis B	2.02e-05	0.00152	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—NFKB1—hepatitis B	1.96e-05	0.00147	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—CDKN1A—hepatitis B	1.93e-05	0.00146	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CYP2A6—hepatitis B	1.91e-05	0.00144	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	1.88e-05	0.00141	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	1.84e-05	0.00138	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	1.83e-05	0.00138	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	1.82e-05	0.00137	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—CDKN1A—hepatitis B	1.73e-05	0.0013	CbGpPWpGaD
Cladribine—RRM1—Metabolism—GOT2—hepatitis B	1.73e-05	0.0013	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—TGFB1—hepatitis B	1.63e-05	0.00123	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—ALB—hepatitis B	1.59e-05	0.0012	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CDKN2A—hepatitis B	1.59e-05	0.0012	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CYP2A6—hepatitis B	1.57e-05	0.00118	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CDKN2A—hepatitis B	1.53e-05	0.00115	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—TNF—hepatitis B	1.52e-05	0.00115	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	1.52e-05	0.00114	CbGpPWpGaD
Cladribine—RRM1—Metabolism—GOT1—hepatitis B	1.49e-05	0.00112	CbGpPWpGaD
Cladribine—RRM1—Metabolism—GGT1—hepatitis B	1.49e-05	0.00112	CbGpPWpGaD
Cladribine—DCK—Metabolism—CYP2A6—hepatitis B	1.47e-05	0.00111	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GOT2—hepatitis B	1.42e-05	0.00107	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CDKN2A—hepatitis B	1.42e-05	0.00107	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	1.42e-05	0.00107	CbGpPWpGaD
Cladribine—PNP—Metabolism—ALB—hepatitis B	1.38e-05	0.00104	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CDKN2A—hepatitis B	1.36e-05	0.00103	CbGpPWpGaD
Cladribine—DCK—Metabolism—GOT2—hepatitis B	1.33e-05	0.001	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CDKN1A—hepatitis B	1.3e-05	0.000978	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	1.25e-05	0.000941	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CDKN1A—hepatitis B	1.25e-05	0.000939	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—IL6—hepatitis B	1.23e-05	0.000925	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GGT1—hepatitis B	1.23e-05	0.000924	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GOT1—hepatitis B	1.23e-05	0.000924	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PTEN—hepatitis B	1.21e-05	0.000914	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—TP53—hepatitis B	1.18e-05	0.000887	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CDKN1A—hepatitis B	1.16e-05	0.000875	CbGpPWpGaD
Cladribine—DCK—Metabolism—GOT1—hepatitis B	1.15e-05	0.000863	CbGpPWpGaD
Cladribine—DCK—Metabolism—GGT1—hepatitis B	1.15e-05	0.000863	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CDKN1A—hepatitis B	1.11e-05	0.00084	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDKN2A—hepatitis B	1.09e-05	0.000819	CbGpPWpGaD
Cladribine—PNP—Metabolism—PTEN—hepatitis B	1.05e-05	0.000793	CbGpPWpGaD
Cladribine—SLC22A2—SLC-mediated transmembrane transport—ALB—hepatitis B	1.01e-05	0.000764	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—AKR1B1—hepatitis B	1.01e-05	0.000762	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—AKR1B1—hepatitis B	1e-05	0.000754	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDKN2A—hepatitis B	9.72e-06	0.000732	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GGT2—hepatitis B	9.7e-06	0.00073	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GGT2—hepatitis B	9.6e-06	0.000723	CbGpPWpGaD
Cladribine—SLC22A1—SLC-mediated transmembrane transport—ALB—hepatitis B	9.46e-06	0.000712	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—AKR1B1—hepatitis B	9.33e-06	0.000703	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GGT2—hepatitis B	8.95e-06	0.000674	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDKN1A—hepatitis B	8.88e-06	0.000669	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDKN1A—hepatitis B	7.94e-06	0.000598	CbGpPWpGaD
Cladribine—RRM1—Metabolism—ALB—hepatitis B	7.92e-06	0.000597	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—TP53—hepatitis B	7.91e-06	0.000596	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—TP53—hepatitis B	7.59e-06	0.000572	CbGpPWpGaD
Cladribine—RRM2—Metabolism—ALB—hepatitis B	6.52e-06	0.000491	CbGpPWpGaD
Cladribine—DCK—Metabolism—ALB—hepatitis B	6.1e-06	0.000459	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PTEN—hepatitis B	6.05e-06	0.000455	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP2A6—hepatitis B	5.88e-06	0.000443	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP2A6—hepatitis B	5.82e-06	0.000438	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP2A6—hepatitis B	5.42e-06	0.000408	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—TP53—hepatitis B	5.41e-06	0.000407	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GOT2—hepatitis B	5.31e-06	0.0004	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GOT2—hepatitis B	5.26e-06	0.000396	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—ALB—hepatitis B	5.21e-06	0.000392	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—ALB—hepatitis B	5.16e-06	0.000388	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PTEN—hepatitis B	4.98e-06	0.000375	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GOT2—hepatitis B	4.9e-06	0.000369	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—ALB—hepatitis B	4.81e-06	0.000362	CbGpPWpGaD
Cladribine—DCK—Metabolism—PTEN—hepatitis B	4.65e-06	0.00035	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GOT1—hepatitis B	4.59e-06	0.000345	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GGT1—hepatitis B	4.59e-06	0.000345	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GGT1—hepatitis B	4.54e-06	0.000342	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GOT1—hepatitis B	4.54e-06	0.000342	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GOT1—hepatitis B	4.23e-06	0.000319	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GGT1—hepatitis B	4.23e-06	0.000319	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ALB—hepatitis B	2.44e-06	0.000184	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ALB—hepatitis B	2.41e-06	0.000182	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ALB—hepatitis B	2.25e-06	0.00017	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PTEN—hepatitis B	1.86e-06	0.00014	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PTEN—hepatitis B	1.84e-06	0.000139	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PTEN—hepatitis B	1.72e-06	0.000129	CbGpPWpGaD
